HYPERTENSIVE NEPHROPATHY

This adverse event was reported 970 times

These drugs are most commonly taken by patients reporting HYPERTENSIVE NEPHROPATHY:

# Drug Count
0 LANSOPRAZOLE 653
1 OMEPRAZOLE MAGNESIUM 506
2 ESOMEPRAZOLE MAGNESIUM 403
3 OMEPRAZOLE 315
4 PANTOPRAZOLE 258
5 ESOMEPRAZOLE SODIUM 247
6 ESOMEPRAZOLE 188
7 LANSOPRAZOLE DELAYED RELEASE 162
8 PANTOPRAZOLE SODIUM 136
9 DEXLANSOPRAZOLE 62
See all common drugs associated with HYPERTENSIVE NEPHROPATHY

HYPERTENSIVE NEPHROPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Proton Pump Inhibitor [EPC] 669 0.0016
1 Sulfonamide Antibacterial [EPC] 2 0.0007
2 Anti-coagulant [EPC] 3 0.0006
3 Vitamin D3 Analog [EPC] 9 0.0005
4 Anthelmintic [EPC] 1 0.0005
5 Human Platelet-derived Growth Factor [EPC] 1 0.0005
6 Chloride Channel Activator [EPC] 3 0.0004
7 Vitamin D2 Analog [EPC] 5 0.0003
8 Thiazide-like Diuretic [EPC] 10 0.0003
9 Central alpha-2 Adrenergic Agonist [EPC] 14 0.0003
See all drug classes enriched for association with HYPERTENSIVE NEPHROPATHY